“We should really consider which kind of therapy is needed because we have to balance how their disease activity is evolving and their pregnancy plan. What is the timeframe for this pregnancy plan—a year, or 2, or 3, or is it quite soon?”

As is the case at any meeting focused on multiple sclerosis (MS) management, at ECTRIMS 2019, September 11-13 in Stockholm, Sweden, the conversation surrounding MS care during pregnancy was a hot topic. For Marie D’hooghe, MD, PhD, neurologist, National MS Center, and consultant neurologist, University Hospital, in Brussels, it was a highlight of a conversation with NeurologyLive.

D’hooghe spoke to the importance of truly ensuring that patients with MS who have any intention of becoming pregnant share that information with their physician, and that physicians are inquiring about their family plans. The differences in the treatment approach can be drastic depending on what the timeline is for each individual.

As well, she noted what clinicians should be aware of when it comes to patients who need to utilize assistive reproductive technology and treatments, as their use can have sway on the patient’s risk of disease relapse.

For more coverage of ECTRIMS 2019, click here.